Product image of Xofigo (Radium Ra 223 Dichloride) supplied by GNH India

Xofigo

Active Ingredient:
Radium Ra 223 Dichloride
Origin:
EU

Xofigo (Radium Ra 223 Dichloride)

Xofigo (Radium Ra 223 Dichloride) is an injectable radiopharmaceutical used for targeted treatment of bone metastases in certain cancers. This alpha-emitting therapy helps manage symptoms and slow disease progression. Suitable for patients with symptomatic bone metastases from prostate cancer.

Manufacturer / TM Owner

Bayer Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xofigo is primarily used to treat bone metastases in patients with advanced prostate cancer that has spread to the bones. It works by targeting areas of increased bone activity, such as metastatic sites, with radiation. This therapy is designed to relieve bone pain and reduce complications from bone metastases. Patients often ask, 'what is Xofigo used for' in the context of managing prostate cancer symptoms.

Side Effects

  • Xofigo is administered via intravenous injection and works by emitting alpha particles that target cancer cells in the bones. Patients may experience relief from bone pain as the treatment helps slow the progression of bone metastases. Some individuals notice improved mobility and reduced need for pain medications over time.

Precautions & Warnings

  • Xofigo should only be handled and administered by healthcare professionals trained in radiopharmaceutical use. Patients receiving Xofigo may need to take precautions to minimize radiation exposure to others, such as limiting close contact with pregnant women or young children. Blood counts should be monitored regularly during treatment.

Avoid Interactions

  • Xofigo may interact with other systemic cancer therapies, including chemotherapy or hormone treatments, though specific interactions vary by patient. Patients should inform their healthcare provider about all medications, supplements, or radiation therapies they are receiving. Bone-modifying agents, such as bisphosphonates, may be used alongside Xofigo but require careful coordination.

Frequently Asked Questions

Xofigo is used to treat bone metastases in patients with advanced prostate cancer that has spread to the bones.

Xofigo is given as an intravenous injection by a healthcare professional.

Xofigo is not a cure but helps manage symptoms and slow disease progression in bone metastases.

Common side effects may include nausea, diarrhea, and low blood cell counts.

Xofigo may be used alongside other therapies, but this should be determined by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Radium Ra 223 Dichloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT